Drug Profile
Research programme: topical wound treatment - AlphaRx
Alternative Names: ARX606TLatest Information Update: 23 Sep 2011
Price :
$50
*
At a glance
- Originator AlphaRx
- Developer AlphaRx; Riso Pharma Tech
- Class Growth factors
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Wounds